Methods for etiologic and early marker investigations in the PLCO trial.

With the rapid development of biomarkers and new technologies, large-scale biologically-based cohort studies present expanding opportunities for population-based research on disease etiology and early detection markers. The prostate, lung, colorectal and ovarian cancer (PLCO) screening trial is a large randomized trial designed to determine if screening for these cancers leads to mortality reduction for these diseases. Within the Trial, the PLCO etiology and early marker study (EEMS) identifies risk factors for cancer and other diseases and evaluates biologic markers for the early detection of disease. EEMS includes 155,000 volunteers who provide basic risk factor information. Serial blood samples are collected at each of six screening rounds (including one collection for cryopreserved whole blood) from screening arm participants (77,000 subjects) and buccal cells are collected from those in the control arm of the trial. Etiologic studies consider environmental (e.g., diet), biochemical, and genetic factors. Early detection studies focus on blood-based biologic markers of early disease. Clinical epidemiology is also an important component of the PLCO trial.

[1]  R. Bast,et al.  Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[2]  T. Paz-Elizur,et al.  DNA repair activity for oxidative damage and risk of lung cancer. , 2003, Journal of the National Cancer Institute.

[3]  J. Gohagan,et al.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.

[4]  G. Izmirlian,et al.  Application of the Random Forest Classification Algorithm to a SELDI‐TOF Proteomics Study in the Setting of a Cancer Prevention Trial , 2004, Annals of the New York Academy of Sciences.

[5]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[6]  E G McFarland,et al.  Spiral CT colonography: reader agreement and diagnostic performance with two- and three-dimensional image-display techniques. , 2001, Radiology.

[7]  Jason Roy,et al.  Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. , 2003, JAMA.

[8]  Christopher A. Haiman,et al.  Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study , 2003, Human Heredity.

[9]  J. Gohagan,et al.  Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  R. Hayes,et al.  Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS , 2005, Analytical and bioanalytical chemistry.

[11]  R. Hayes,et al.  Variability in flexible sigmoidoscopy performance among examiners in a screening trial. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  H R Garner,et al.  Repeat polymorphisms within gene regions: phenotypic and evolutionary implications. , 2000, American journal of human genetics.

[13]  E. Petricoin,et al.  Clinical proteomics: translating benchside promise into bedside reality , 2002, Nature Reviews Drug Discovery.

[14]  Josef Korinek,et al.  Proceedings of the American Society of Clinical Oncology , 1982 .

[15]  Benjamin Littenberg,et al.  CT colonography: multiobserver diagnostic performance. , 2002, Radiology.

[16]  J. Gohagan,et al.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. , 2000, Controlled clinical trials.

[17]  Matthew W. Hahn,et al.  The evolution of transcriptional regulation in eukaryotes. , 2003, Molecular biology and evolution.

[18]  P Vineis,et al.  Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. , 2000, Journal of the National Cancer Institute.

[19]  David J Brenner,et al.  Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. , 2003, American journal of human genetics.

[20]  Emanuel F. Petricoin,et al.  High-resolution serum proteomic features for ovarian cancer detection. , 2004 .

[21]  D. Moore,et al.  On the frequency of chromosome exchanges in a control population measured by chromosome painting. , 1994, Mutation research.

[22]  Halima Bensmail,et al.  A novel approach for clustering proteomics data using Bayesian fast Fourier transform , 2005, Bioinform..

[23]  Jeffrey S. Morris,et al.  Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..

[24]  D. Ransohoff.  Rules of evidence for cancer molecular-marker discovery and validation , 2004, Nature Reviews Cancer.

[25]  J. Gohagan,et al.  Relationship of demographic and clinical factors to free and total prostate-specific antigen. , 2001, Urology.

[26]  R. Hayes,et al.  Whole blood cryopreservation in epidemiological studies. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  J. Gohagan,et al.  Results of repeat sigmoidoscopy 3 years after a negative examination. , 2003, JAMA.

[28]  H. Norppa,et al.  Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective , 2004, Cytogenetic and Genome Research.

[29]  David Ward,et al.  Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data , 2003, Bioinform..

[30]  Christopher I Amos,et al.  Genetic susceptibility to lung cancer: the role of DNA damage and repair. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  D Pinkel,et al.  Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. , 1990, Mutation research.

[32]  N. Guitton,et al.  Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. , 2004, European journal of cancer.

[33]  William L. Bigbee,et al.  Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[34]  M. Cornforth,et al.  CO-FISH reveals inversions associated with isochromosome formation. , 1996, Mutagenesis.